Cas no 101927-49-5 (9H-Pyrido[3,4-b]indol-6-ol,5,7-dibromo-)
![9H-Pyrido[3,4-b]indol-6-ol,5,7-dibromo- structure](https://ossimg.kuujia.com/scimg/102000/101927-49-5x500.png)
101927-49-5 structure
Product Name:9H-Pyrido[3,4-b]indol-6-ol,5,7-dibromo-
CAS No:101927-49-5
MF:C11H6Br2N2O
MW:341.986140727997
CID:146703
PubChem ID:127993
Update Time:2025-04-19
9H-Pyrido[3,4-b]indol-6-ol,5,7-dibromo- Chemical and Physical Properties
Names and Identifiers
-
- 9H-Pyrido[3,4-b]indol-6-ol,5,7-dibromo-
- 5,7-dibromo-9H-pyrido[3,4-b]indol-6-ol
- 7-bromoeudistomine D
- 5,7-dibromo-9H-beta-carbolin-6-ol
- 5,7-Dibromo-9H-prido(3,4-b)indol-6-ol
- 9H-Prido(3,4-b)indol-6-ol, 5,7-dibromo-
- Bromo-eudistomin D
- SCHEMBL7085913
- BDBM50207817
- 7-bromo-eudistomin D
- 101927-49-5
- DTXSID80144350
- PD092596
- CHEMBL272185
-
- Inchi： 1S/C11H6Br2N2O/c12-6-3-7-9(10(13)11(6)16)5-1-2-14-4-8(5)15-7/h1-4,15-16H
- InChI Key： UNIUKKWPGRGSRQ-UHFFFAOYSA-N
- SMILES： BrC1=C(C(=CC2=C1C1C=CN=CC=1N2)Br)O
Computed Properties
- Exact Mass: 339.88468
- Monoisotopic Mass: 339.88469g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 16
- Rotatable Bond Count: 0
- Complexity: 279
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.3
- Topological Polar Surface Area: 48.9?2
Experimental Properties
- PSA: 48.91
9H-Pyrido[3,4-b]indol-6-ol,5,7-dibromo- Related Literature
-
Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
-
Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
101927-49-5 (9H-Pyrido[3,4-b]indol-6-ol,5,7-dibromo-) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)
Recommended suppliers
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Reagent
Henan Dongyan Pharmaceutical Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Hunan Well Medicine Synthesis Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier
CN Supplier
Reagent
HANGZHOU BAIS CHEMICAL TECHNOLOGY CO., LTD.
Gold Member
Audited Supplier
CN Supplier
Reagent
